Skip to main content
HR 1810 112th Congress House Health Cardiovascular and respiratory health Drug therapy Government information and archives Health information and medical records Health programs administration and funding Medical education Medical research

Tom Lantos Pulmonary Hypertension Research and Education Act of 2011

Introduced: May 10, 2011 See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 13, 2011
Referred to the Subcommittee on Health.
May 10, 2011
Referred to the House Committee on Energy and Commerce.
May 10, 2011
Introduced in House
 Plain-English summary Congressional Research Service

Tom Lantos Pulmonary Hypertension Research and Education Act of 2011 - Expresses the sense of Congress that: (1) the Secretary of Health and Human Services (HHS), acting through the Director of the National Institutes of Health (NIH) and the Director of the National Heart, Lung, and Blood Institute, should continue aggressive work on pulmonary hypertension; and (2) the Director of the Institute should continue research to expand the understanding of the causes of, and to find a cure for, pulmonary hypertension.

Requires inclusion of information on the status of pulmonary hypertension research at NIH in biennial reports to Congress.

Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to carry out an educational campaign to increase public awareness of pulmonary hypertension, which may include information on pulmonary hypertension and its symptoms, the incidence and prevalence of pulmonary hypertension, diseases and conditions that can lead to pulmonary hypertension as a secondary diagnosis, the importance of early diagnosis, and the availability of a range of treatment options.

Requires the Secretary, acting through the Administrator of the Health Resources and Services Administration (HRSA) and the Director of CDC, to carry out an educational campaign to increase awareness of pulmonary hypertension among health care providers, which may include information on: (1) the symptoms of pulmonary hypertension, (2) the importance of early diagnosis, (3) current diagnostic criteria, and (4) Food and Drug Administration (FDA)-approved therapies for the disease. Requires such campaign to target health care providers, including cardiologists, pulmonologists, rheumatologists, primary care physicians, pediatricians, and nurse practitioners.

What's happening now May 13, 2011

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2